Form 4 for LENZ LENZ Therapeutics, Inc.
Accepted 2024-05-14 00:00:00 ET · period of report 2024-05-13 · accession 0001815776-24-000044 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-05-14 | 2024-05-13 | LENZ | MCCOLLUM JAMES W | Dir | P - Purchase | $15.99 | +31.3K | 525.6K | +6% | +$501.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-13 | P | A | 31,332 | $15.99 | 525,565 | I By trust | — | — | (F1) Represents the weighted average share price of an aggregate total of 31,332 shares purchased in the price range of $15.96 to $16.00 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |